Freethink
•77% Informative
CRISPR tary angioedema is a rare but serious disorder that causes severe swelling in t first nds, feet, face, and other parts of the body.
People with the condition have first n one c mutation that prevents their body from making a blood protein called “C1-Inhibitor” This leads to the buildup of another protein, “kallikrein,” which is what triggers their swelling attacks.
Intellia Therapeutics' CRISPR treatment, called "NTLA-2002," has performed well in its first human trial. GuardianGurugama class="summaryFeed_highLightText__NxlGi">18 months three yFeed_highLightTe every month 54-year-old several days yFeed_highLightText__NxlGi">Cleveland first $2.2 million every few days lGi">CRISPR IV n class="summar 100% d_highLightText__NxlGi">FDA Casgevy Amazing ">t Intellia Therapeutics pan> CRISPR an> 2024 1 class="summaryFeed_highLightText first G one 2 CRISPR Padmalal Gurugama Intellia Guardian span class="summaryFeed_highLight every three weeks months the past 18 months 7 months nine six 95%< C1-Inhibitor n class="summaryFeed_highLightText__NxlGi">16-week 75 Intellia ass CRISPR aryFeed_highLightTex NTLA-2002 >50 25 1 NxlGi">t 10 ee IV i">one
VR Score
72
Informative language
70
Neutral language
11
Article tone
informal
Language
English
Language complexity
49
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
6
Source diversity
6
Affiliate links
no affiliate links